A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers

Trial Profile

A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs MABp1 (Primary)
  • Indications Acne vulgaris; Cachexia; Colorectal cancer; Haematological malignancies; Non-small cell lung cancer; Plaque psoriasis; Pyoderma; Type 2 diabetes mellitus; Vascular restenosis
  • Focus Pharmacokinetics; Registrational
  • Sponsors XBiotech
  • Most Recent Events

    • 26 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 22 Feb 2017 According to a XBiotech media release, dosing of subjects has been completed in this trial.
    • 22 Feb 2017 Status changed from recruiting to active, no longer recruiting based on announcement of dosing completion in an XBiotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top